Kai Riecke
Publications by Year
Research Areas
Iron Metabolism and Disorders, Antibiotics Pharmacokinetics and Efficacy, Animal testing and alternatives, Hemoglobinopathies and Related Disorders, Contact Dermatitis and Allergies
Most-Cited Works
- → Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans(2014)109 cited
- → Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia(2019)85 cited
- → Safety, pharmacokinetics and pharmacodynamics of the anti‐hepcidin Spiegelmer lexaptepid pegol in healthy subjects(2016)80 cited
- → Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study(2017)80 cited
- → An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay(2005)65 cited
- → An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: First round(2005)53 cited
- → Sensitising potential of four textile dyes and some of their metabolites in a modified local lymph node assay(2006)48 cited
- → Low doses of 2,3,7,8-tetrachlorodibenzo- p -dioxin increase transforming growth factor β and cause myocardial fibrosis in marmosets ( Callithrix jacchus )(2002)48 cited
- → The Effects of Weak and Strong CYP3A Induction by Rifampicin on the Pharmacokinetics of Five Progestins and Ethinylestradiol Compared to Midazolam(2020)29 cited
- → Pharmacokinetics, Safety, and Tolerability of the Novel Tetrameric, High-Relaxivity, Macrocyclic Gadolinium-Based Contrast Agent Gadoquatrane in Healthy Adults(2023)23 cited